CCTG EN10: A phase II study of tailored adjuvant therapy in POLE -mutated and p53-wildtype/NSMP early-stage endometrial cancer (EC)—RAINBO BLUE and TAPER.

Authors :: McAlpine, Jessica N.
Han, Kathy Chai-Zung
Kinloch, Mary
Barkati, Maroie
Ferguson, Sarah E.
Fyles, Anthony W.
Huang, Fleur
Kong, Iwa
Kwon, Janice S.
Mackay, Helen
Carey, Mark Stafford
Welch, Stephen
Bosse, Tjalling
Creutzberg, Carien L.
Horeweg, Nanda
Leary, Alexandra
Liu, WenLing
Tu, Dongsheng
Parulekar, Wendy R.
Source :: Journal of Clinical Oncology; 2023 Supplement 16, Vol. 41, pTPS5632-TPS5632, 1p
Publication Year :: 2023

Full Text Access

Tools